# Arachidonic Acid Supplementation in Very Preterm Infants

> **NCT02503020** · PHASE2 · COMPLETED · sponsor: **Health Research Institute of Santiago** · enrollment: 45 (actual)

## Conditions studied

- Impaired Psychomotor Development

## Interventions

- **DIETARY_SUPPLEMENT:** Preterm infants formula A
- **DIETARY_SUPPLEMENT:** Preterm infants formula B

## Key facts

- **NCT ID:** NCT02503020
- **Lead sponsor:** Health Research Institute of Santiago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-11
- **Final completion:** 2015-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503020, "Arachidonic Acid Supplementation in Very Preterm Infants". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02503020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*